文献速递乳腺癌放疗

肿瘤整形保乳重建与辅助放射治疗在乳腺癌中的相互作用

Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer.
PubMed 文献 · Adv Radiat Oncol · 2023-11-04

该研究回顾了2014至2019年间接受保乳术联合即刻肿瘤整形保乳手术(OBS)及辅助全乳放疗的局限性乳腺癌女性。OBS采用容积移位技术,患者接受三维适形全乳照射。结果显示放疗剂量学计划可接受,切除更多组织未带来显著放疗或手术优势。

要点

  • OBS术中额外切除的同侧乳腺组织体积范围为21至2086 cm³(中位数304 cm³),29%的患者切除体积>500 cm³。
  • 手术切缘阳性率为12.5%,且不受切除乳腺组织体积影响(445 vs 439 cm³)。
  • 有手术夹的患者更常接受瘤床增量照射(75.9% vs 50.0%),有夹者增量体积平均157 cm³,无夹者205 cm³。

核心结论

  • 接受肿瘤整形手术患者的放疗剂量学计划可接受,切除更多组织的患者未获得显著放疗或手术优势。
  • 研究强调外科医生与放射肿瘤科医生就充分标记瘤床进行清晰沟通的重要性,采用可最大限度减少再次切除需求及最大限度减少重排过程中瘤床破坏的做法。

研究设计与样本

  • 回顾性分析2014至2019年间接受保乳术联合即刻OBS及辅助放疗的局限性乳腺癌女性。
  • OBS采用容积移位技术,患者接受三维适形全乳照射。

主要发现

  • OBS术中额外切除的同侧乳腺组织体积范围为21至2086 cm³(中位数304 cm³),29%的患者切除体积>500 cm³。
  • 手术切缘阳性率为12.5%,且不受切除乳腺组织体积影响(445 vs 439 cm³)。
  • 有手术夹的患者更常接受瘤床增量照射(75.9% vs 50.0%),有夹者增量体积平均157 cm³,无夹者205 cm³。
  • 切除组织>500 cm³且照射乳腺体积>1000 cm³的患者平均V105相当,而后间距>26 cm的患者绝对体积更高(58.0 cm³ vs 102.7 cm³;P = .07)。
  • 对于后间距>26 cm、切除乳腺组织>500 cm³或照射乳腺体积>1000 cm³的患者,Dmax或放疗覆盖(95%体积接受95%处方剂量)未见有意义的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Oncoplastic breast surgery (OBS) combines breast cancer tumor removal with the cosmetic benefits of plastic surgery at the time of breast-conserving surgery. Potential advantages of OBS include wider surgical margins around the tumor bed, while the natural shape and appearance of the breast are maintained more than standard lumpectomy procedures. However, limited information is available regarding the potential effect on adjuvant radiation treatment planning. MATERIALS AND METHODS: Women with localized breast cancer undergoing lumpectomy with immediate OBS and adjuvant radiation therapy between 2014 and 2019 were reviewed. OBS was performed using volume displacement techniques and patients received whole-breast irradiation with 3-dimensional conformal radiation therapy. RESULTS: Volume of additional ipsilateral breast tissue removed during OBS ranged from 21 to 2086 cm3 (median, 304 cm3), 29% of patients had >500 cm3 of tissue removed. Surgical margins were positive in 12.5% and were not affected by volume of breast tissue removed (445 vs 439 cm3). Patients with surgical clips more often received a lumpectomy bed boost (75.9% vs 50.0%), boost volumes were on average 157 cm3 with clips versus 205 cm3 without clips. Mean V105 was comparable in patients with >500 cm3 tissue removed and irradiated breast volume >1000 cm3, while higher absolute volumes were found in patients with >26 cm posterior separation (58.0 cm3 vs 102.7 cm3; P = .07). No meaningful difference was observed in Dmax or radiation coverage (95% of the volume receiving 95% of the prescription dose) for patients with >26 cm posterior separation, >500 cm3 of breast tissue removed, or irradiated breast volume >1000 cm3. CONCLUSIONS: Radiation dosimetry plans for patients undergoing oncoplastic surgery were acceptable and no significant radiation or surgical advantage was gained in patients with more tissue removed. Our study stresses the importance of clear communication between surgeons and radiation oncologists about sufficient marking of the lumpectomy cavity, using practices that minimize the need for re-excisions and minimize lumpectomy cavity disruption during rearrangement.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Morse RT, Moreno M, Butterworth JA, et al. Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer. Adv Radiat Oncol. 2023. PMID: 38495037. doi:10.1016/j.adro.2023.101403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。